Calreticulin and cancer

J Fucikova, R Spisek, G Kroemer, L Galluzzi - Cell research, 2021 - nature.com
Calreticulin (CALR) is an endoplasmic reticulum (ER)-resident protein involved in a
spectrum of cellular processes. In healthy cells, CALR operates as a chaperone and Ca2+ …

Leukaemia: a model metastatic disease

AE Whiteley, TT Price, G Cantelli, DA Sipkins - Nature Reviews Cancer, 2021 - nature.com
In contrast to solid cancers, which often require genetic modifications and complex cellular
reprogramming for effective metastatic dissemination, leukaemic cells uniquely possess the …

[PDF][PDF] Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy

D Forte, M García-Fernández, A Sanchez-Aguilera… - Cell metabolism, 2020 - cell.com
Like normal hematopoietic stem cells, leukemic stem cells depend on their bone marrow
(BM) microenvironment for survival, but the underlying mechanisms remain largely …

Catch me if you can: how AML and its niche escape immunotherapy

S Tettamanti, A Pievani, A Biondi, G Dotti, M Serafini - Leukemia, 2022 - nature.com
In spite of the remarkable progress in basic and preclinical studies of acute myeloid
leukemia (AML), the five-year survival rate of AML patients remains poor, highlighting the …

The role of tumor microenvironment in multiple myeloma development and progression

A Garcia-Ortiz, Y Rodriguez-Garcia, J Encinas… - Cancers, 2021 - mdpi.com
Simple Summary Multiple Myeloma (MM) is a hematologic malignancy caused by aberrant
plasma cell proliferation in the bone marrow (BM) and constitutes the second most common …

Chronic myeloid leukemia: a model disease of the past, present and future

VR Minciacchi, R Kumar, DS Krause - Cells, 2021 - mdpi.com
Chronic myeloid leukemia (CML) has been a “model disease” with a long history. Beginning
with the first discovery of leukemia and the description of the Philadelphia Chromosome and …

Deep downregulation of PD‐L1 by caged peptide‐conjugated AIEgen/miR‐140 nanoparticles for enhanced immunotherapy

J Dai, JJ Hu, X Dong, B Chen, X Dong… - Angewandte Chemie …, 2022 - Wiley Online Library
Downregulating programmed cell death ligand 1 (PD‐L1) protein levels in tumor cells is an
effective way to achieve immune system activation for oncology treatment, but current …

[PDF][PDF] Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis

NB Leimkühler, HFE Gleitz, L Ronghui, IAM Snoeren… - Cell Stem Cell, 2021 - cell.com
Functional contributions of individual cellular components of the bone-marrow
microenvironment to myelofibrosis (MF) in patients with myeloproliferative neoplasms …

[HTML][HTML] Mitochondrial transfer and regulators of mesenchymal stromal cell function and therapeutic efficacy

A Mohammadalipour, SP Dumbali… - Frontiers in Cell and …, 2020 - frontiersin.org
Mesenchymal stromal cell (MSC) metabolism plays a crucial role in the microenvironment in
both normal physiology and disease. While MSCs predominantly utilize glycolysis in their …

Evolving cancer–niche interactions and therapeutic targets during bone metastasis

RL Satcher, XHF Zhang - Nature Reviews Cancer, 2022 - nature.com
Many cancer types metastasize to bone. This propensity may be a product of genetic traits of
the primary tumour in some cancers. Upon arrival, cancer cells establish interactions with …